personalized-health
(6)
Rony Sellam
Rony Sellam is the CEO of InsideTracker, a Cambridge, Massachusetts based personalized-health company that uses blood biomarkers, DNA and lifestyle data to give consumers actionable recommendations for extending healthspan. A former Deloitte consultant from France by way of Geneva and a longtime healthcare IT executive, he has run InsideTracker for over a decade and helped push the company past 100,000 members and into partnerships with Oura and Fitness SF.
GENETICA® US
Genetica is a San Francisco-founded gene decoding company built for Asian genomes. It pairs a proprietary genotyping chip - manufactured with Illumina and Thermo Fisher - with AI analysis to turn a saliva sample into reports on health risks, innate ability, behavior, nutrition and fitness. Marketed direct-to-consumer across Vietnam and Southeast Asia, its CLIA- and CAP-certified pipeline is reviewed by scientists tied to UCSF, Harvard, Stanford and Cornell.
Tiny Health
Tiny Health is an Austin-based health company that built the first at-home gut microbiome test designed for babies, then extended the same clinically-validated science to children, pregnant people, adults and longevity. It pairs DNA sequencing of stool and vaginal samples with age-specific reference ranges and personalized, research-backed recommendations, aiming to catch early microbiome imbalances linked to eczema, allergies, digestive issues and chronic conditions before they take hold.
Signos
Signos is a San Francisco Bay Area digital health company pairing a continuous glucose monitor with an AI-driven app to help non-diabetic adults lose weight and improve metabolic health through real-time, personalized feedback on food, sleep, stress and exercise.
Vivoo
Vivoo is a San Francisco-based health tech company that makes at-home urine test strips analyzed via smartphone camera. Founded in 2017, the company offers a wellness platform that measures 8+ biomarkers — including hydration, vitamins, minerals, pH, ketones, and oxidative stress — and delivers personalized nutrition and lifestyle recommendations through a free mobile app. Backed by $19.4M in funding led by Tim Draper, Vivoo is sold at Target, Walmart, and Sam's Club, and has expanded to 100+ countries with a focus on making lab-grade health insights accessible to everyday consumers.
Sharam Fouladgar-Mercer
Sharam Fouladgar-Mercer is the Co-Founder and CEO of Signos, the company behind the first FDA-cleared over-the-counter glucose monitoring system for weight management. A Princeton computer science graduate and Harvard MBA, he played NCAA Division I ice hockey before building a career spanning VC at Sierra and Shasta Ventures, co-founding PR tech company AirPR (later Onclusive), and ultimately creating Signos in 2018 after his own lifelong struggle with weight and the death of his diabetic grandmother inspired him to ask: why wait until someone is sick to give them metabolic data?